Hubert J.P. Schoemaker Leadership Award This award recognizes an outstanding leader in the bioscience community who best exemplifies the spirit of innovation in the Commonwealth of Pennsylvania. Dr. Hubert J.P. Schoemaker was one of the bioscience industry’s leading scientists and entrepreneurs, founding Centocor (now Janssen Biotech Inc.), and later, Garnet Biotherapeutics (formerly Neuronyx, Inc.). He was widely noted as an inspiration and mentor to many industry CEOs, scientists, and executives. His vision for the industry and for the region, as well as his spirit and will to succeed, remain among his great legacies.The recipient of the Hubert J.P. Schoemaker leadership Award must have demonstrated a vision for the industry and for improving the lives of patients. The honoree is selected by the Pennsylvania Bio Executive Committee from nominations provided by the Board of Directors. Past recipients include: Frank Baldino, Jr. Ph.D., founder, former Chairman and CEO, Cephalon (2006) , David Holveck, President & CEO, Endo Pharmaceuticals (2007), Jean-Pierre Garnier, Ph.D., former CEO, GlaxoSmithKline (2008), Joseph Scodari, former Worldwide Chairman, Johnson & Johnson Pharmaceuticals (2009), Brenda Gavin, Partner, Quaker BioVentures (2010), Bruce Peacock, Partner, SV Life Sciences Advisors (2011), Warren "Pete" Musser, former Chairman and CEO, Safeguard Scientifics, Inc. (2012)Frank Baldino Bioscience CEO of the Year AwardRecognizes a CEO who has demonstrated visionary leadership and active participation to advance the industry. He or she will have a record of proven, exceptional achievement as well as a commitment to the biosciences for the benefit of patients. The recipient will be from a small company with less than 250 employees. The honoree is selected by the Pennsylvania Bio Executive Committee from nominations provided by the Board of Directors.2012 Deal of the Year AwardRecognizes a company that has promoted the growth of Pennsylvania’s bioscience industry by way of a substantial deal or strategic partnership. The company receiving the Pennsylvania Bio Deal of the Year Award will have closed a deal or strategic partnership that resulted in the continued growth and advancement of Pennsylvania’s bioscience industry. The deal can have occurred at any stage of product development or level of company maturity. In order to qualify, the deal must have closed in the previous year. The honoree is selected by the Pennsylvania Bio Board of Directors from nominations provided by a selection committee.Scientific Achievement AwardRecognizes a scientist in the Pennsylvania bioscience community who has demonstrated outstanding achievement by advancing scientific knowledge, innovation, and/or patient care. The honoree is chosen by a selection committee from the academic/research community.Federal Public Official of the Year AwardRecognizes a public official from the Commonwealth of Pennsylvania who has demonstrated outstanding leadership on behalf of the bioscience industry. The honoree is selected by the Pennsylvania Bio Board Advocacy Committee from nominations provided by Pennsylvania Bio’s Federal Legislative Advocacy Committee. State Public Official of the YearRecognizes a public official from the Commonwealth of Pennsylvania who has distinguished him/herself as a leader in the bioscience industry. The honoree is selected by the Pennsylvania Bio Board Advocacy Committee from nominations provided by Pennsylvania Bio’s State Public Policy committee.President’s Service AwardRecognizes an association member who has made a significant contribution to the organization through volunteering their time, leadership and energy to help advance Pennsylvania Bio’s mission of creating a cohesive community that unites Pennsylvania’s biotechnology, medical device, diagnostic, pharmaceutical, research and financial strengths. The honoree is selected by the Pennsylvania Bio Board of Directors from nominations by the staff of Pennsylvania Bio. *Board members are not eligible for this awardPatient Impact Award Recognizes a company or organization that has made a significant contribution to the quality of health care or length of life of patients in 2012. Eligible organizations include medical device, diagnostic, pharmaceutical, biotechnology companies or academic institutions with significant operations in Pennsylvania. The honored organization will be selected by a committee of leaders from Pennsylvania hospital groups from nominations provided by individuals in Pennsylvania’s life science community. Emerging Leader Recognition Program-must purchase a table in order to make a nomination.Pennsylvania Bio would like to give our member companies an opportunity to recognize their emerging leaders at our Annual Dinner. Nominate one emerging leader from any discipline within your organization who demonstrates leadership qualities, vision and a sense of commitment to their colleagues, organization and the life sciences industry. Nominees will be confirmed by PA Bio staff.Benefits for Emerging Leaders include:· Recognition at the Annual Dinner· Listing in Annual Dinner program· Listing in Philadelphia Business Journal· Listing on the 2013 Annual Dinner Website
Cvent Online Event Registration Software | Copyright © 2000-2013 Cvent Inc. All rights reserved.